VSTM
Verastem, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.20
+2.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.86x
- Price / sales
- 8.48x
- Price / cash flow
- -4.58x
Enterprise value
- Enterprise value
- $690.6M
- EV / sales
- 7.89x
- EV / EBITDA
- -3.46x
- EV / EBIT
- -4.32x
- Market cap
- $742.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026